Canada Pension Plan Investment Board boosted its stake in DaVita HealthCare Partners Inc. (NYSE:DVA) by 33.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 387,370 shares of the company’s stock after buying an additional 96,282 shares during the period. Canada Pension Plan Investment Board’s holdings in DaVita HealthCare Partners were worth $25,086,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in DVA. Speece Thorson Capital Group Inc. raised its stake in shares of DaVita HealthCare Partners by 0.5% in the second quarter. Speece Thorson Capital Group Inc. now owns 280,515 shares of the company’s stock valued at $18,166,000 after buying an additional 1,360 shares in the last quarter. PGGM Investments purchased a new stake in shares of DaVita HealthCare Partners during the second quarter valued at approximately $28,598,000. Founders Capital Management LLC raised its stake in shares of DaVita HealthCare Partners by 0.6% in the second quarter. Founders Capital Management LLC now owns 93,824 shares of the company’s stock valued at $6,076,000 after buying an additional 520 shares in the last quarter. Eqis Capital Management Inc. raised its stake in shares of DaVita HealthCare Partners by 2.2% in the second quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock valued at $298,000 after buying an additional 100 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. raised its stake in shares of DaVita HealthCare Partners by 491.6% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 25,274 shares of the company’s stock valued at $1,637,000 after buying an additional 21,002 shares in the last quarter. Institutional investors own 83.53% of the company’s stock.

DaVita HealthCare Partners Inc. (NYSE DVA) opened at 56.55 on Monday. DaVita HealthCare Partners Inc. has a one year low of $54.50 and a one year high of $70.16. The stock has a market cap of $10.81 billion, a P/E ratio of 8.61 and a beta of 0.89. The company has a 50-day moving average price of $62.89 and a 200-day moving average price of $65.66.

DaVita HealthCare Partners (NYSE:DVA) last released its earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The business had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.82 billion. During the same period last year, the business earned $1.01 earnings per share. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, analysts anticipate that DaVita HealthCare Partners Inc. will post $3.57 earnings per share for the current year.

WARNING: This news story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/14/davita-healthcare-partners-inc-nysedva-shares-bought-by-canada-pension-plan-investment-board.html.

Several brokerages have commented on DVA. BidaskClub lowered DaVita HealthCare Partners from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 5th. TheStreet downgraded DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research report on Wednesday, August 2nd. Zacks Investment Research raised DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $70.00 target price on shares of DaVita HealthCare Partners in a research report on Thursday, August 3rd. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and issued a $62.00 target price on shares of DaVita HealthCare Partners in a research report on Thursday, May 25th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $68.89.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.